文献速递神经肿瘤

高级别胶质瘤:联合使用5-氨基乙酰丙酸与术中超声进行切除及检测的预测算法

High-grade glioma: combined use of 5-aminolevulinic acid and intraoperative ultrasound for resection and a predictor algorithm for detection.
PubMed 文献 · J Neurosurg · 2025-04-18

该单中心研究纳入2019年1月至2024年1月72例高级别胶质瘤患者,评估联合5-ALA荧光与术中超声检测残留肿瘤的效能,并开发机器学习算法HGGPredictor预测活检肿瘤存在。联合检测阳性/阳性时灵敏度91%、特异度86%,优于单独使用任一技术。

要点

  • 5-ALA与术中超声联合阳性/阳性时灵敏度91%、特异度86%。
  • 单独5-ALA灵敏度84.9%、特异度57.8%;单独ioUS灵敏度76%、特异度84.5%。
  • HGGPredictor算法可估算手术切缘肿瘤细胞数量。

核心结论

  • 联合5-ALA和ioUS提高了高级别胶质瘤切除的诊断准确性,提示可能成为新的手术标准。
  • 术中预测算法可进一步自动化决策。

研究设计与样本

  • 单中心研究,2019年1月至2024年1月纳入72例高级别胶质瘤切除患者,平均年龄62.2岁,男性占62.5%。
  • 肿瘤组织学包括胶质母细胞瘤(90.3%)、IV级星形细胞瘤(4.1%)、III级星形细胞瘤(2.8%)和III级少突胶质细胞瘤(2.8%)。
  • 先在自然光下切除,再用5-ALA和ioUS检测残留肿瘤,对手术床活检组织进行组织学分析。
  • 5-ALA和ioUS结果分为阳性、弱/可疑或阴性;活检组织学分为实性肿瘤、浸润或无肿瘤。
  • 计算两种技术单独及联合的灵敏度、特异度和预测值,并开发机器学习算法HGGPredictor预测活检中肿瘤存在。

主要发现

  • 5-ALA总体灵敏度84.9%、特异度57.8%;ioUS总体灵敏度76%、特异度84.5%。
  • 联合阳性/阳性场景性能最高,灵敏度91%、特异度86%。
  • 联合阳性/可疑场景次之,灵敏度67.9%、特异度95.2%。
  • 曲线下面积分析表明两种技术联合优于各自单独使用。
  • HGGPredictor工具能有效估算手术切缘的肿瘤细胞数量。

临床怎么用

  • 作者认为联合5-ALA和ioUS提高了高级别胶质瘤切除的诊断准确性,提示可能成为新的手术标准。
  • 作者认为术中预测算法可进一步自动化决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary goal in neuro-oncology is the maximally safe resection of high-grade glioma (HGG). A more extensive resection improves both overall and disease-free survival, while a complication-free surgery enables better tolerance to adjuvant therapies such as chemotherapy and radiotherapy. Techniques such as 5-aminolevulinic acid (5-ALA) fluorescence and intraoperative ultrasound (ioUS) are valuable for safe resection and cost-effective. However, the benefits of combining these techniques remain undocumented. The aim of this study was to investigate outcomes when combining 5-ALA and ioUS. METHODS: From January 2019 to January 2024, 72 patients (mean age 62.2 years, 62.5% male) underwent HGG resection at a single hospital. Tumor histology included glioblastoma (90.3%), grade IV astrocytoma (4.1%), grade III astrocytoma (2.8%), and grade III oligodendroglioma (2.8%). Tumor resection was performed under natural light, followed by using 5-ALA and ioUS to detect residual tumor. Biopsies from the surgical bed were analyzed for tumor presence and categorized based on 5-ALA and ioUS results. Results of 5-ALA and ioUS were classified into positive, weak/doubtful, or negative. Histological findings of the biopsies were categorized into solid tumor, infiltration, or no tumor. Sensitivity, specificity, and predictive values for both techniques, separately and combined, were calculated. A machine learning algorithm (HGGPredictor) was developed to predict tumor presence in biopsies. RESULTS: The overall sensitivities of 5-ALA and ioUS were 84.9% and 76%, with specificities of 57.8% and 84.5%, respectively. The combination of both methods in a positive/positive scenario yielded the highest performance, achieving a sensitivity of 91% and specificity of 86%. The positive/doubtful combination followed, with sensitivity of 67.9% and specificity of 95.2%. Area under the curve analysis indicated superior performance when both techniques were combined, in comparison to each method used individually. Additionally, the HGGPredictor tool effectively estimated the quantity of tumor cells in surgical margins. CONCLUSIONS: Combining 5-ALA and ioUS enhanced diagnostic accuracy for HGG resection, suggesting a new surgical standard. An intraoperative predictive algorithm could further automate decision-making.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Aibar-Durán JÁ, Mirapeix RM, Gallardo Alcañiz A, et al. High-grade glioma: combined use of 5-aminolevulinic acid and intraoperative ultrasound for resection and a predictor algorithm for detection. J Neurosurg. 2025. PMID: 40250048. doi:10.3171/2024.12.JNS242496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。